Bristol-Myers (BMY) stock is in focus as a psoriasis therapy from Takeda (TAK) outperforms the company's FDA approved therapy Sotyktu in a late-stage trial. Read more here.

An Oklahoma lawmaker is urging the Oklahoma Corporation Commission to protect Public Service Company of Oklahoma (PSO) residential customers in the latest PSO rate case.

State Question 846 will soon allow Oklahomans in August the opportunity to decide if the existing state's voter ID ...

A research team has developed an optimized energy management strategy for a hybrid residential microgrid that combines solar ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...